SOLVSolventum Corpvs its industry peers
A metric-by-metric comparison of Solventum Corp against Health Care Select Sector SPDR Fund holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLVEsta | $15.1B#15 | 10.9x#1 | 3.1x#3 | 1.8x#3 | 0.9%#13 | 224.8%#3 | 26.2%#6 | 32.4%#6 | 20.9%#6 | 6#2 | 20.3%#7 | — |
| LLY | $1.10T#1 | 39.3x#11 | 32.5x#14 | 16.9x#15 | 44.7%#1 | 94.9%#5 | 40.2%#1 | 60.9%#3 | 26.3%#2 | — | 55.8%#3 | 0.5%#11 |
| JNJ | $649.0B#2 | 31.2x#8 | 7.6x#8 | 6.9x#11 | 6.0%#8 | 90.6%#6 | 22.9%#9 | 31.5%#8 | 16.1%#8 | 6#2 | 57.5%#2 | 1.9%#10 |
| ABBV | $468.8B#3 | 74.9x#13 | — | 7.7x#12 | 8.6%#6 | -1.2%#11 | 24.6%#8 | — | 18.6%#7 | — | 22.1%#6 | 2.5%#4 |
| UNH | $334.7B#5 | 24.0x#4 | 10.1x#11 | 0.7x#2 | 11.8%#3 | -16.3%#13 | 4.2%#14 | 36.5%#5 | 21.3%#5 | — | 11.9%#9 | 2.4%#5 |
| MRK | $372.7B#4 | 120.9x#14 | 8.9x#10 | 5.7x#8 | 1.3%#12 | 6.6%#9 | 34.2%#3 | 43.5%#4 | 21.6%#4 | — | 92.0%#1 | 2.2%#8 |
| AMGN | $221.9B#7 | 25.5x#5 | 19.0x#13 | 6.0x#9 | 10.0%#4 | 88.5%#7 | 24.7%#7 | 66.0%#2 | 15.1%#9 | — | — | 2.3%#6 |
| TMO | $243.6B#6 | 35.5x#9 | 4.6x#5 | 5.5x#7 | 3.9%#10 | 6.0%#10 | 17.4%#12 | 12.8%#11 | 10.1%#11 | — | 39.1%#4 | 0.3%#12 |
| ABT | $180.7B#9 | 29.1x#6 | 3.5x#4 | 4.1x#6 | 5.7%#9 | -51.3%#14 | 18.2%#11 | 12.5%#12 | 8.3%#12 | — | -22.3%#10 | 2.3%#7 |
| GILD | $189.3B#8 | — | 16.0x#12 | 6.4x#10 | 2.4%#11 | 1672.9%#1 | 34.0%#4 | 71.9%#1 | 26.7%#1 | — | — | 2.1%#9 |
| ISRG | $142.0B#11 | 46.1x#12 | 7.8x#9 | 14.1x#14 | 20.5%#2 | 23.0%#8 | 29.3%#5 | 15.7%#10 | — | — | — | — |
| PFE | $159.2B#10 | 36.8x#10 | 1.9x#2 | 2.5x#4 | -1.6%#15 | -3.2%#12 | 16.3%#13 | 9.1%#13 | 6.9%#13 | — | 23.3%#5 | 6.1%#1 |
| CVS | $111.4B#14 | 23.0x#3 | 1.4x#1 | 0.3x#1 | 7.8%#7 | -61.7%#15 | 1.2%#15 | 2.2%#14 | 2.9%#14 | 6#2 | 19.4%#8 | 3.1%#3 |
| VRTX | $130.5B#12 | 30.0x#7 | 6.4x#7 | 10.9x#13 | 8.9%#5 | 838.1%#2 | 34.8%#2 | 19.5%#9 | 25.0%#3 | — | — | — |
| BMY | $127.1B#13 | 13.7x#2 | 5.7x#6 | 2.6x#5 | -0.2%#14 | 178.8%#4 | 21.8%#10 | 31.6%#7 | 14.0%#10 | 7#1 | — | 4.0%#2 |
Peer set: top holdings of XLV (Health Care Select Sector SPDR Fund), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-23.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice